SGT-003

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)NCT07160634SLDBPhase 3Recruiting2029-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.